文献速递心血管CT

光谱光子计数探测器冠状动脉CTA在炎症相关冠状动脉疾病中采用降低的辐射和对比剂剂量的前瞻性研究

Spectral Photon-Counting Detector Coronary CTA With Reduced Radiation and Contrast Medium Dose in Inflammation-Associated Coronary Artery Disease: A Prospective Study.
PubMed 文献 · AJR Am J Roentgenol · 2025-12-24

这项前瞻性研究纳入63例炎症相关冠状动脉疾病患者,采用光谱光子计数探测器冠状动脉CTA(前瞻性心电触发序列采集、个体化低剂量对比剂方案),比较55 keV虚拟单能成像与多色T3D成像的图像质量和诊断性能,以有创冠状动脉造影为参考。结果显示55 keV VMI图像质量更优,在检测阻塞性狭窄方面每病灶准确率更高,而在支架内再狭窄检测方面两种重建图像无显著差异。

要点

  • 55 keV VMI较T3D图像质量、诊断信心、SNR和CNR更优。
  • 55 keV VMI对阻塞性狭窄的每病灶准确率高于T3D(读者1:96.2% vs 84.1%;读者2:97.0% vs 86.4%)。
  • 两种重建图像对支架内再狭窄的准确率无显著差异。

核心结论

  • 光谱光子计数探测器冠状动脉CTA采用低辐射和对比剂剂量并以55 keV VMI重建,在检测炎症相关冠状动脉疾病患者的阻塞性狭窄和支架内再狭窄方面显示出优异的诊断准确率。

研究设计与样本

  • 前瞻性研究,纳入2022年1月至2024年3月炎症相关冠状动脉疾病患者63例(平均年龄50.4±11.5岁;45例女性,18例男性),采用光谱光子计数探测器冠状动脉CTA前瞻性心电触发序列采集和个体化低剂量对比剂方案,以有创冠状动脉造影为参考标准。

诊断标准与关键数值

  • 以有创冠状动脉造影为参考,在40例患者、132个病变和75个支架中评估诊断性能;55 keV VMI较T3D图像的每病灶准确率更高(读者1:96.2% vs 84.1%;读者2:97.0% vs 86.4%),差异在非钙化和部分钙化斑块、中远段病变及BMI≥24患者中亦可见;支架内再狭窄准确率无显著差异(读者1:97.3% vs 96.0%;读者2:96.0% vs 94.7%)。

临床应用与阅片要点

  • 作者提出该方案可用于指导炎症相关冠状动脉疾病的临床决策。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Patients with inflammation-associated coronary artery disease (CAD) may exhibit rapid progression and require regular coronary imaging. OBJECTIVE. The purpose of this article was to evaluate the diagnostic performance of spectral photon-counting detector (PCD) coronary CTA with reduced radiation and contrast medium dose for detecting coronary stenosis and in-stent restenosis in patients with inflammation-associated CAD. METHODS. This prospective study enrolled patients with inflammation-associated CAD from January 2022 to March 2024. Participants underwent spectral PCD coronary CTA using prospectively ECG-triggered sequential acquisition and an individualized low-dose contrast medium protocol. Images were reconstructed with virtual monoenergetic imaging (VMI) at 55 keV and polychromatic (T3D) imaging using matching parameters, including 0.4-mm slice thickness. Two readers independently assessed subjective (5-point Likert scales) and objective image quality measures; readers also assessed images for obstructive stenosis and in-stent restenosis (both ≥ 50%) in patients with invasive coronary angiography (ICA) available as a reference. RESULTS. The analysis included 63 patients (mean age, 50.4 ± 11.5 [SD] years; 45 women, 18 men). Median contrast medium volume was 28.0 mL. Median DLP was 165.0 mGy ∙ cm. Images from 55-keV VMI, compared with those from T3D imaging, showed better (p < .05) overall image quality, diagnostic confidence, SNR, and CNR in all three assessed vessels (e.g., right coronary artery for reader 1: overall image quality of 4.5 vs 4.1 and CNR of 12.1 vs 9.9). Diagnostic performance using ICA as the reference was evaluated in 40 patients with 132 lesions and 75 stents. Images from 55-keV VMI, compared with those from T3D imaging, showed higher (p < .05) per-lesion accuracy for obstructive stenosis (reader 1: 96.2% vs 84.1%; reader 2: 97.0% vs 86.4%); these differences in accuracy were also observed for both readers for noncalcified and partly calcified plaques, lesions in mid and distal segments, and patients with a BMI of 24 and greater. Images from 55-keV VMI and T3D imaging showed no significant difference (p > .05) in accuracy for in-stent restenosis (reader 1: 97.3% vs 96.0%; reader 2: 96.0% vs 94.7%). CONCLUSION. Spectral PCD coronary CTA, performed using low radiation and contrast medium dose and reconstructed using 55-keV VMI, showed excellent diagnostic accuracy in detecting obstructive stenosis and in-stent restenosis in patients with inflammation-associated CAD. CLINICAL IMPACT. The proposed protocol could be used to guide clinical decision-making in inflammation-associated CAD.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Xu C, Sun Y, Wang L, et al. Spectral Photon-Counting Detector Coronary CTA With Reduced Radiation and Contrast Medium Dose in Inflammation-Associated Coronary Artery Disease: A Prospective Study. AJR Am J Roentgenol. 2025. PMID: 40928168. doi:10.2214/AJR.25.33493

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。